Clinical Trial Update: Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CT041 as postoperative adjuvant therapy for gastric and gastroesophageal junction adenocarcinoma; the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• CT041 (Claudin18.2-targeted CAR-T cell therapy)

Snippet

Sponsor: Peking University | Conditions: Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma | Phase 1 | Status: NOT_YET_RECRUITING